TCL Archive Excerpts From Potti’s Application to Practice Medicine In South Carolina December 9, 2011
TCL Archive Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.” December 16, 2005
TCL Archive Cancer Research Emphasis Grants (CREG) Offered As A New Way To Fund Contract Research Efforts November 23, 1974
TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
